285 related articles for article (PubMed ID: 26464214)
1. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Shearer RF; Iconomou M; Watts CK; Saunders DN
Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase UBR5 regulates centriolar satellite stability and primary cilia.
Shearer RF; Frikstad KM; McKenna J; McCloy RA; Deng N; Burgess A; Stokke T; Patzke S; Saunders DN
Mol Biol Cell; 2018 Jul; 29(13):1542-1554. PubMed ID: 29742019
[TBL] [Abstract][Full Text] [Related]
3. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD.
Bethard JR; Zheng H; Roberts L; Eblen ST
J Proteomics; 2011 Dec; 75(2):603-9. PubMed ID: 21924388
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
5. The MLLE domain of the ubiquitin ligase UBR5 binds to its catalytic domain to regulate substrate binding.
Muñoz-Escobar J; Matta-Camacho E; Kozlov G; Gehring K
J Biol Chem; 2015 Sep; 290(37):22841-50. PubMed ID: 26224628
[TBL] [Abstract][Full Text] [Related]
6. The role of UBR5 in tumor proliferation and oncotherapy.
Hu B; Chen S
Gene; 2024 May; 906():148258. PubMed ID: 38331119
[TBL] [Abstract][Full Text] [Related]
7. The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.
Gong X; Du D; Deng Y; Zhou Y; Sun L; Yuan S
Invest New Drugs; 2020 Apr; 38(2):515-524. PubMed ID: 32008177
[TBL] [Abstract][Full Text] [Related]
8.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
9. Systematic approaches to identify E3 ligase substrates.
Iconomou M; Saunders DN
Biochem J; 2016 Nov; 473(22):4083-4101. PubMed ID: 27834739
[TBL] [Abstract][Full Text] [Related]
10. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
11. Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer.
Xie Z; Liang H; Wang J; Xu X; Zhu Y; Guo A; Shen X; Cao F; Chang W
Oncotarget; 2017 Dec; 8(64):108079-108092. PubMed ID: 29296225
[TBL] [Abstract][Full Text] [Related]
12. VprBP (DCAF1): a promiscuous substrate recognition subunit that incorporates into both RING-family CRL4 and HECT-family EDD/UBR5 E3 ubiquitin ligases.
Nakagawa T; Mondal K; Swanson PC
BMC Mol Biol; 2013 Sep; 14():22. PubMed ID: 24028781
[TBL] [Abstract][Full Text] [Related]
13. Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen.
Schukur L; Zimmermann T; Niewoehner O; Kerr G; Gleim S; Bauer-Probst B; Knapp B; Galli GG; Liang X; Mendiola A; Reece-Hoyes J; Rapti M; Barbosa I; Reschke M; Radimerski T; Thoma CR
Sci Rep; 2020 Nov; 10(1):20044. PubMed ID: 33208877
[TBL] [Abstract][Full Text] [Related]
14. Cryo-EM structure of the chain-elongating E3 ubiquitin ligase UBR5.
Hodáková Z; Grishkovskaya I; Brunner HL; Bolhuis DL; Belačić K; Schleiffer A; Kotisch H; Brown NG; Haselbach D
EMBO J; 2023 Aug; 42(16):e113348. PubMed ID: 37409633
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
16. Structure of the human UBR5 E3 ubiquitin ligase.
Wang F; He Q; Zhan W; Yu Z; Finkin-Groner E; Ma X; Lin G; Li H
Structure; 2023 May; 31(5):541-552.e4. PubMed ID: 37040767
[TBL] [Abstract][Full Text] [Related]
17. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
Front Oncol; 2021; 11():634167. PubMed ID: 33777788
[TBL] [Abstract][Full Text] [Related]
18. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin ligase UBR5 interacts with the H/ACA ribonucleoprotein complex and regulates ribosomal RNA biogenesis in embryonic stem cells.
Saez I; Gerbracht JV; Koyuncu S; Lee HJ; Horn M; Kroef V; Denzel MS; Dieterich C; Gehring NH; Vilchez D
FEBS Lett; 2020 Jan; 594(1):175-188. PubMed ID: 31365120
[TBL] [Abstract][Full Text] [Related]
20. UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells.
Swenson SA; Gilbreath TJ; Vahle H; Hynes-Smith RW; Graham JH; Law HC; Amador C; Woods NT; Green MR; Buckley SM
Blood; 2020 Jul; 136(3):299-312. PubMed ID: 32325489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
